Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8M Sell
122,881
-4,557
-4% -$533K 0.67% 18
2026
Q1
$15.3M Sell
127,438
-119
-0.1% -$13.7K 0.71% 17
2025
Q4
$13.4M Sell
127,557
-28,212
-18% -$2.65M 0.58% 23
2025
Q3
$13.1M Buy
155,769
+560
+0.4% +$46.1K 0.55% 25
2025
Q2
$12.3M Buy
155,209
+49,557
+47% +$3.94M 0.54% 26
2025
Q1
$9.48M Sell
105,652
-28,230
-21% -$2.64M 0.42% 47
2024
Q4
$13.3M Buy
+133,882
New +$13.8M 0.54% 29

Other funds holding MRK

New Age Alpha Advisors's MRK Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Merck (MRK) stake by 3.6% in Q2 2026, selling an estimated $533K and leaving 122,881 shares worth $15.8M. The position accounts for 0.67% of the portfolio, ranked #18.

New Age Alpha Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • New Age Alpha Advisors held 122,881 shares of Merck worth $15.8M as of Q2 2026.
  • New Age Alpha Advisors sold 4,557 Merck shares in Q2 2026, an estimated $533K.
  • Merck made up 0.67% of New Age Alpha Advisors's portfolio in Q2 2026, its #18 holding.
  • New Age Alpha Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.